Showing results (21-30 of 26) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
The Oncologist|December 21, 2020
Benefit-Risk Summary of Nivolumab for the Treatment of Patients with Unresectable Advanced, Recurrent, or Metastatic Esophageal Squamous Cell Carcinoma After Prior Fluoropyrimidine- and Platinum-Based ChemotherapyLorraine Pelosof, May Tun Saung, Martha Donoghue, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2024
FDA Approval Summary: Olutasidenib for Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase 1 MutationAshley C Woods, Kelly J Norsworthy, Moran Choe, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2020
FDA Approval Summary: Atezolizumab Plus Bevacizumab for the Treatment of Patients with Advanced Unresectable or Metastatic Hepatocellular CarcinomaSandra J Casak, Martha Donoghue, Lola Fashoyin-Aje, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2020
FDA Approval Summary: Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf Injection for Subcutaneous Use in Patients with HER2-positive Breast CancerJennifer J Gao, Christy L Osgood, Yutao Gong, et al.Clinical Pharmacology and Therapeutics|June 5, 2025
Using Quantitative Approaches to Optimize Dosages for New Combinations and Subsequent Indications for Oncology DrugsWei Gao, Jiang Liu, Cynthia J Musante, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2020
FDA Approval Summary: Alpelisib Plus Fulvestrant for Patients with HR-positive, HER2-negative, PIK3CA-mutated, Advanced or Metastatic Breast CancerPreeti Narayan, Tatiana M Prowell, Jennifer J Gao, et al.Pageof 3